The diagnosis of DIL in our patient was supported by the clinical presentation, history of hydralazine use, laboratory findings of anemia and leukopenia, elevated inflammatory markers, and presence of autoantibodies, specifically positive anti-histone and ANA. This evidence concerns the gene BTG3 and anemia (phenotype).